CSTB and cancer: Interestingly, the clinical data indicated a high-power correlation of the low expression of CSTB in the ITF with local recurrence, resulted from aggressive or advanced tumors, as an independent prognostic marker (Supplementary Data 25), using the criteria for the consideration of a marker for cancer prognosis based on the REMARK guidelines51.